Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

Metformin was proposed to be a candidate for host-directed therapy for COVID-19. However, its efficacy remains to be validated. In this study, we compared the outcome of metformin users and nonusers in hospitalized COVID-19 patients with diabetes. Hospitalized diabetic patients with confirmed COVID-...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The American journal of tropical medicine and hygiene Ročník 103; číslo 1; s. 69
Hlavní autori:	Luo, Pan, Qiu, Lin, Liu, Yi, Liu, Xiu-Lan, Zheng, Jian-Ling, Xue, Hui-Ying, Liu, Wen-Hua, Liu, Dong, Li, Juan
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.07.2020
Predmet:	Aged Betacoronavirus China Coronavirus Infections - complications Coronavirus Infections - mortality Coronavirus Infections - therapy COVID-19 Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Female Hospital Mortality Humans Hypoglycemic Agents - therapeutic use Length of Stay Male Metformin - therapeutic use Middle Aged Pandemics Pneumonia, Viral - complications Pneumonia, Viral - mortality Pneumonia, Viral - therapy Retrospective Studies SARS-CoV-2 China
ISSN:	1476-1645, 1476-1645
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!